Hacker News Reader

Ipi/nivo/relatlimab and then a peptide vaccine that they haven't written up yet.

Thanks for the link to the paper. I notice that the abstract has a link to the page for the upcoming trial:

It will be interesting to follow its progress.

In news announced a few minutes ago, Richard Scolyer's cancer has come back and the prognosis is a few months to live.